For example, Wnt-5a is increased in melanoma [60], colorectal cancer [61], pancreatic cancer [62], non-small cell lung cancer [63, 64], renal cell carcinoma [64] and glioma [65, 66]. Here, WNT5A is linked to pancreatic neoplasm.